ArticleThe oncologist2024

Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.

Andreas Reichinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.